Pharmalink Healthcare

Trelegy Ellipta (Fluticasone Furoate 100 mcg / Umeclidinium 62.5 mcg / Vilanterol 25 mcg) is a combination inhaler used to manage chronic obstructive pulmonary disease (COPD) and asthma. It combines a corticosteroid (fluticasone) to reduce inflammation, a long-acting muscarinic antagonist (umeclidinium) to relax airway muscles, and a long-acting beta-agonist (vilanterol) to open airways. This triple therapy improves breathing, reduces flare-ups, and enhances lung function. Used once daily under medical supervision.